Submission of Matters to a Vote of Security Holders Form 8 K

Item 5.07 Submission of Matters to a Vote of Security Holders.

On July 23, 2024, Tenon Medical, Inc., a Delaware corporation (the "Company"), held its virtual 2024 Annual Stockholders Meeting (the "Meeting").

As of the close of business on June 3, 2024, the record date for the determination of stockholders entitled to vote at the Meeting, there were 6,348,000 shares of the Company's common stock, par value $0.001 per share, issued and outstanding, with each share entitled to one vote on each proposal at the Meeting. At the Meeting, the combined holders of 3,639,345 shares of the voting stock entitled to notice of and to vote at the Meeting were represented in person or by proxy, representing approximately 57.33% of the outstanding voting shares, and thereby a quorum pursuant to the Delaware General Corporation Law and the bylaws of the Company was present for the transaction of business at the Meeting.

The final results for each of the matters considered at the Meeting were as follows:

1.	Election of the seven nominees to the Board of Directors of the Company:

Name		Votes For		Withheld		Broker Non-Votes
Richard Ferrari		2,401,226		35,492		1,202,627
Steven Foster		2,414,743		21,975		1,202,627
Richard Ginn		2,406,883		29,835		1,202,627
Stephen Hochschuler, MD		2,412,845		23,873		1,202,627
Ivan Howard		2,384,482		52,236		1,202,627
Kristine Jacques		2,416,095		20,623		1,202,627
Robert Weigle		2,383,773		52,945		1,202,627

Each director nominee was elected to serve as a director until the Company's 2025 annual meeting of stockholders, or until such person's successor is duly elected and qualified, or until such person's earlier resignation, death or removal. Due to the fact that directors are elected by a plurality of the votes cast, votes could only be cast in favor of or withheld from the nominees and thus votes against were not applicable.

2.

Approval of the terms of (i) our Series B Preferred Stock, (ii) the warrants to be issued on the issuance date of our Series B Preferred Stock and (iii) the amendment to the terms of our Series A Preferred Stock to decrease the amount of the conversion price thereof, in each case, to comply with Listing Rule 5635(d) of The Nasdaq Stock Market LLC:

Votes For		Votes Against		Abstentions		Broker Non-Votes
2,391,579		45,130		8		1,202,628

The affirmative vote of the holders of a majority of the shares represented at the Meeting and entitled to vote was required for approval. The proposal was approved.

3.	Approval of amendments to the Tenon Medical, Inc. 2022 Equity Incentive Plan (the "2022 Plan") to (i) increase the total number of shares of the Company's common stock subject to the 2022 Plan by 1,100,000 shares and (ii) permit the issuance of equity awards to individuals and legal entities:

Votes For		Votes Against		Abstentions		Broker Non-Votes
2,318,386		117,137		1,195		1,202,627

The affirmative vote of the holders of a majority of the shares represented at the Meeting and entitled to vote was required for approval. The proposal was approved.

4.	Ratification of the selection by the Board of Directors of the Company of Haskell & White LLP as its independent auditor for the fiscal year ending December 31, 2024:

Votes For		Votes Against		Abstentions
3,609,093		11,604		18,648

The affirmative vote of the holders of a majority of the shares represented at the Meeting and entitled to vote was required for approval. The proposal was approved.

5.

Approval of adjourning the Meeting, if necessary, to solicit additional proxies in the event there are not sufficient votes in favor of the proposals listed above at the time of the Meeting:

Votes For		Votes Against		Abstentions
2,720,153		141,255		777,935

The affirmative vote of the holders of a majority of the shares represented at the Meeting and entitled to vote was required for approval. The proposal was approved.

Public link

Please use the above public link if you want to share this noodl on another website.